{"id":"W2998319702","doi":"10.1016/j.jaad.2019.12.038","title":"Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":false,"ca_institutions":"SKiN Health","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Psoriasis Area and Severity Index; Ustekinumab; Secukinumab; Etanercept; Psoriasis; Adalimumab; Infliximab; Cumulative dose; Anakinra; Internal medicine; Dermatology; Psoriatic arthritis; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0008655703,0.0005852735,0.01429762,0.0003532697,0.00008272227,0.000002837769,0.001293511,0.0008770426,0.0000595434],"category_scores_gemma":[0.0003611675,0.0002637461,0.01045666,0.0009038502,0.001394175,0.00003958131,0.0001435004,0.0005471148,0.000003999188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006996992,"about_ca_system_score_gemma":0.000234722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001611957,"about_ca_topic_score_gemma":0.00001911072,"domain_scores_codex":[0.9906756,0.00320452,0.005189323,0.0004073169,0.0001491329,0.0003740721],"domain_scores_gemma":[0.961723,0.01511462,0.02227005,0.0006362977,0.0002189735,0.00003703304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003375418,0.001443773,0.007792749,0.0004297952,0.6831194,0.000001208916,0.0004275817,0.0006597285,0.00002643203,0.0002320468,0.003214282,0.2992776],"study_design_scores_gemma":[0.003106423,0.002015735,0.004326169,0.000375503,0.6809134,0.00007569224,0.000193471,0.00001159936,0.0009224887,0.0001577034,0.3076183,0.0002834979],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01840974,0.976487,0.00006322205,0.0004732316,0.0006164541,0.0008579696,0.003067682,0.000003833614,0.00002082777],"genre_scores_gemma":[0.06995314,0.9290479,0.0005583689,0.00005641518,0.0001267539,0.00002713947,0.0001174457,0.00002758349,0.00008529864],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3044041,"threshold_uncertainty_score":0.9999815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2985425094853917,"score_gpt":0.4549858454893279,"score_spread":0.1564433360039362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}